Literature DB >> 27197819

The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study.

Masaya Suda1, Tomonari Kiriyama2, Keiichi Ishihara3, Masahisa Onoguchi4, Yasuhiro Kobayashi2, Minoru Sakurai3, Takayuki Shibutani4, Shin-Ichiro Kumita2.   

Abstract

BACKGROUND: Motion artifact and partial volume effect caused underestimation of coronary plaque inflammation. This study evaluated the high matrix acquisition technique using time-of-flight (TOF) positron emission tomography/computed tomography for imaging of atherosclerotic plaque inflammation with fluorine-18 fluorodeoxyglucose in small and moving phantoms. METHODS AND
RESULTS: All images were reconstructed using a conventional algorithm without TOF (4 × 4 × 4 mm3 voxel size) and a high matrix algorithm with TOF (2 × 2 × 2 mm3 voxel size). Microsphere phantoms of 10, 7.9, 6.2, 5.0, and 4.0 mm diameters were acquired in 3-dimensional list-mode for 30 minutes. A heart phantom mimicking cardiac motion consisted of a hot spot simulating a plaque (φ 4 mm, φ 2 mm) on the outside of the left ventricle. In the microsphere and heart phantom study, visual discrimination, maximum activity, and target-to-background ratio using the high matrix algorithm with TOF were better than those using the conventional algorithm without TOF.
CONCLUSION: The high matrix algorithm with TOF improves detection of small targets in phantoms.

Entities:  

Keywords:  18F-fluorodeoxyglucose; Plaque imaging; atherosclerotic plaque; inflammation; positron emission tomography; time-of-flight

Mesh:

Substances:

Year:  2016        PMID: 27197819     DOI: 10.1007/s12350-016-0510-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  22 in total

Review 1.  Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

Authors:  Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

2.  Benefit of time-of-flight in PET: experimental and clinical results.

Authors:  Joel S Karp; Suleman Surti; Margaret E Daube-Witherspoon; Gerd Muehllehner
Journal:  J Nucl Med       Date:  2008-02-20       Impact factor: 10.057

Review 3.  Imaging the vulnerable plaque.

Authors:  David Vancraeynest; Agnes Pasquet; Véronique Roelants; Bernhard L Gerber; Jean-Louis J Vanoverschelde
Journal:  J Am Coll Cardiol       Date:  2011-05-17       Impact factor: 24.094

4.  Association of vascular 18F-FDG uptake with vascular calcification.

Authors:  Mark P S Dunphy; Alvin Freiman; Steven M Larson; H William Strauss
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

5.  Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.

Authors:  Ian S Rogers; Khurram Nasir; Amparo L Figueroa; Ricardo C Cury; Udo Hoffmann; David A Vermylen; Thomas J Brady; Ahmed Tawakol
Journal:  JACC Cardiovasc Imaging       Date:  2010-04

6.  Time-of-flight positron emission tomography: status relative to conventional PET.

Authors:  T F Budinger
Journal:  J Nucl Med       Date:  1983-01       Impact factor: 10.057

Review 7.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

8.  Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Mark Woodward; Valentin Fuster; Michael E Farkouh; Zahi A Fayad
Journal:  Circ Cardiovasc Imaging       Date:  2009-01-26       Impact factor: 7.792

9.  Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.

Authors:  Zahi A Fayad; Venkatesh Mani; Mark Woodward; David Kallend; Markus Abt; Tracy Burgess; Valentin Fuster; Christie M Ballantyne; Evan A Stein; Jean-Claude Tardif; James H F Rudd; Michael E Farkouh; Ahmed Tawakol
Journal:  Lancet       Date:  2011-09-09       Impact factor: 79.321

10.  18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

Authors:  Nikhil V Joshi; Alex T Vesey; Michelle C Williams; Anoop S V Shah; Patrick A Calvert; Felicity H M Craighead; Su Ern Yeoh; William Wallace; Donald Salter; Alison M Fletcher; Edwin J R van Beek; Andrew D Flapan; Neal G Uren; Miles W H Behan; Nicholas L M Cruden; Nicholas L Mills; Keith A A Fox; James H F Rudd; Marc R Dweck; David E Newby
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

View more
  2 in total

1.  The dream of imaging coronary artery inflammation with FDG PET/CT imaging.

Authors:  R Glenn Wells; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2016-06-03       Impact factor: 5.952

Review 2.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.